| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/05/2009 | US20090062322 Novel Tricyclic Spiropiperidines or Spiropyrrolidines |
| 03/05/2009 | US20090062316 Deuterium-enriched pelitrexol |
| 03/05/2009 | US20090062307 aminopyrazine derivatives; ROCK inhibitors; 3-(1-ethyl-1H-imidazo[4,5-c]pyridin-2-yl)pyrazin-2-amine; antiinflammatory, antidiabetic, antiproliferative agents |
| 03/05/2009 | US20090062290 Heterocycles as potassium channel modulators |
| 03/05/2009 | US20090062280 Ophthalmic Compositions for Treating Ocular Hypertension |
| 03/05/2009 | US20090062276 Pyridopyrimidine protein tyrosine phosphatase inhibitors |
| 03/05/2009 | US20090062275 stem cell factor receptor antagonists such as 3-{4-[(4-(trifluoromethoxy)benzyl)oxy]phenyl}-N-(2-morpholin-4-ylethyl)-3H-imidazo[4,5-b]pyridine-6-carboxamide, used for the treatment of cancer and tumors; anticarcinogenic and antitumor agents |
| 03/05/2009 | US20090062274 Pyridopyrimidinone inhibitors of pi3kalpha |
| 03/05/2009 | US20090062273 3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same. |
| 03/05/2009 | US20090062272 Imidazoquinolinyl sulfonamides |
| 03/05/2009 | US20090062267 L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS |
| 03/05/2009 | US20090062262 Non steroidal glucocorticoid receptor modulators |
| 03/05/2009 | US20090062253 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 03/05/2009 | US20090061005 Paliperidone Polymorphs |
| 03/05/2009 | US20090057613 Fluorescent quinacridones |
| 03/05/2009 | US20090056793 Benzoterrylene derivatives |
| 03/05/2009 | CA2698075A1 Antiviral drugs for treatment of arenavirus infection |
| 03/05/2009 | CA2698071A1 Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 03/05/2009 | CA2697971A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/05/2009 | CA2696898A1 Process for the preparation of pyrido [2,1-a] isoquinoline derivatives and polymorphic forms thereof |
| 03/05/2009 | CA2691448A1 Triazolopyridine compounds and their use as ask inhibitors |
| 03/04/2009 | EP2029596A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 03/04/2009 | EP2029595A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 03/04/2009 | EP2029594A1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 03/04/2009 | EP2029593A1 Indole derivatives |
| 03/04/2009 | EP2029592A1 Pharmaceutical compounds |
| 03/04/2009 | EP2029591A1 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof |
| 03/04/2009 | EP2029590A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydro-imidazopyridine and tetrahydrotriazolopyridine derivatives and use thereof |
| 03/04/2009 | EP2029589A1 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof |
| 03/04/2009 | EP2029588A2 Tetrahydropyrido[3,4-d]pyrimidines and related analogues |
| 03/04/2009 | EP2029575A1 Substituted spirocyclic cgrp receptor antagonists |
| 03/04/2009 | EP2029573A1 Dibenzorylenetetracarboximides as infrared absorbers |
| 03/04/2009 | EP2029571A1 Substituted 3 -amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments |
| 03/04/2009 | EP2029559A1 Aryl-4-ethynyl-isoxazole derivatives |
| 03/04/2009 | EP2029551A2 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 03/04/2009 | EP2029543A2 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 03/04/2009 | EP2029532A2 Piperazine enamines as antiviral agents |
| 03/04/2009 | EP2029503A1 11c/18 f-labeled inhibitors of glycogen synthase kinase-3 |
| 03/04/2009 | EP1729777B1 Pharmaceutical composition comprising a salt of mirtazapine |
| 03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1379269B1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 03/04/2009 | CN101379063A 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/04/2009 | CN101379062A 3,9-diazabicyclo [3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/04/2009 | CN101379061A Inhibitors of E1 activating enzyme |
| 03/04/2009 | CN101379056A Compounds for the inhibition of integrins and use thereof |
| 03/04/2009 | CN101379055A Substituted quinolones III |
| 03/04/2009 | CN101379041A Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 03/04/2009 | CN101379033A Secondary amines |
| 03/04/2009 | CA2697051A1 Substituted-quinoxaline-type piperidine compounds and the uses thereof |
| 03/03/2009 | US7498442 Quinolinone-carboxamide compounds |
| 03/03/2009 | US7498439 Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content |
| 03/03/2009 | US7498438 Fused ring NK1 antagonists |
| 03/03/2009 | US7498349 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 03/03/2009 | US7498343 Mycobacterial inhibitors |
| 03/03/2009 | US7498342 Compounds modulating c-kit activity |
| 03/03/2009 | US7498341 antidiabetic agents; type 2 diabetes |
| 03/03/2009 | US7498336 anticancer agents; to regulate p53 and MDM2 stability and activity; 10-(3-chloro-phenyl)-7-nitro-10H-pyrimido[4,5-b]quinoline-2,4-dione, and 10-(4-chloro-phenyl)-7-nitro-10H-pyrimido[4,5-b]quinoline-2,4-dione |
| 03/03/2009 | US7498332 Therapy for cerebral vasospasm |
| 03/03/2009 | US7498328 Derivatives of sulphonamides, their preparation and use as medicaments |
| 03/03/2009 | US7498327 Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands |
| 03/03/2009 | US7498326 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
| 03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 02/26/2009 | WO2009026446A2 Hdac inhibitors |
| 02/26/2009 | WO2009026326A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026319A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | WO2009026241A1 Heterocyclic modulators of tgr5 |
| 02/26/2009 | WO2009026197A1 Novel cathepsin c inhibitors and their use |
| 02/26/2009 | WO2009024825A1 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors |
| 02/26/2009 | WO2009024613A1 Tetracyclic indolopyridines as eg5 inhibitors |
| 02/26/2009 | WO2009024517A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands |
| 02/26/2009 | WO2009024516A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 02/26/2009 | WO2009024515A1 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands |
| 02/26/2009 | WO2009024190A1 Indolopyridines as inhibitors of the kinesin spindle protein (eg5 ) |
| 02/26/2009 | WO2009004557A3 A process for the preparation of intermediates of tetracyclic compounds |
| 02/26/2009 | WO2008155572A3 Fused quinoline derivatives useful as gaba modulators |
| 02/26/2009 | WO2008137084A3 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 02/26/2009 | US20090054479 Fused heterocyclic derivatives as ppar modulators |
| 02/26/2009 | US20090054478 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| 02/26/2009 | US20090054477 4-thio substituted quinoline and naphthyridine compounds |
| 02/26/2009 | US20090054476 A3 Adenosine receptor allosteric modulators |
| 02/26/2009 | US20090054471 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs |
| 02/26/2009 | US20090054459 Substituted indoles |
| 02/26/2009 | US20090054440 Quinoline derivatives as neurokinin receptor antagonists |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054408 2-(2-Oxo-3-pyridin-2-ylimidazolidin-1-yl)-N-(2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide; CGRP (Calcitonin Gene-Related Peptide); headache, migraine or cluster headache |
| 02/26/2009 | US20090054400 New progesterone receptor modulators |
| 02/26/2009 | US20090054399 Hiv integrase inhibitors |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090053172 Heterocyclic compounds as ccr5 antagonists |
| 02/26/2009 | CA2697246A1 Indolopyridines as inhibitors of the kinesin spindle protein (eg5) |
| 02/26/2009 | CA2697100A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | CA2696680A1 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands |
| 02/26/2009 | CA2696631A1 Heterocycles as potassium channel modulators |
| 02/26/2009 | CA2695452A1 Hdac inhibitors |
| 02/25/2009 | EP2027123A2 Compounds and compositions as protein kinase inhibitors |
| 02/25/2009 | EP2027122A1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 02/25/2009 | EP2026809A2 Reversion of malignant phenotype with 9-hydroxy ellipticine derivatives |